RISKS OF SABR FOR EARLY-STAGE NON-SMALL CELL LUNG CANCER WITH CO-EXISTING INTERSTITIAL LUNG DISEASE: A SYSTEMATIC REVIEW OF LITERATURE

被引：0
|
作者：
Chen, Hanbo [1 ]
Louie, Alexander [1 ]
Boldt, R. Gabriel [1 ]
Palma, David [1 ]
Nossent, Esther [2 ]
Senan, Suresh [2 ]
机构：
[1] Univ Western Ontario, London, ON, Canada
[2] Vrije Univ Amsterdam, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
238
引用
收藏
页码：S86 / S87
页数：2
相关论文
共 50 条
  • [31] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
  • [32] Navigating restriction from interstitial lung disease (ILD) with stereotactic ablative radiotherapy (SABR) in early-stage non-small cell lung cancer: soaring beyond the current treatment paradigm
    Kassardjian, Ari A.
    Malhotra, Jyoti
    Lee, Percy
    TRANSLATIONAL CANCER RESEARCH, 2025, 14 (01) : 11 - 15
  • [33] Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC)
    Nick Jovanoski
    Seye Abogunrin
    Danilo Di Maio
    Rossella Belleli
    Pollyanna Hudson
    Sneha Bhadti
    Libby G. Jones
    PharmacoEconomics, 2023, 41 : 1437 - 1452
  • [34] Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC)
    Jovanoski, Nick
    Abogunrin, Seye
    Di Maio, Danilo
    Belleli, Rossella
    Hudson, Pollyanna
    Bhadti, Sneha
    Jones, Libby G. G.
    PHARMACOECONOMICS, 2023, 41 (11) : 1437 - 1452
  • [35] Treatment Toxicity and Outcomes Following Definitive Radiotherapy for Patients with Early-Stage Non -Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease A Systematic Review
    Li, G. J.
    Soon, M. Sam
    Chen, H.
    Boldt, G.
    Bahig, H.
    Cheung, P.
    Palma, D. A.
    Ryerson, C.
    Senan, S.
    Louie, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E37 - E38
  • [36] Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more
    White, Abby
    Swanson, Scott J.
    JOURNAL OF THORACIC DISEASE, 2016, 8 : S399 - S405
  • [37] LUNG CANCER WITH CO-EXISTING INTERSTITIAL LUNG DISEASE: INCIDENCE, TREATMENT AND OUTCOMES
    Bhatnagar, M.
    Farthing, L.
    Storey, C.
    Murphy, C.
    Haney, S.
    THORAX, 2022, 77 : A136 - A137
  • [38] Lung Tissue Transcriptome as Predictor of Recurrence in Early-stage Non-small Cell Lung Cancer
    Darawshy, F.
    Dolgalev, I.
    Wu, B. G.
    Li, Y.
    Kwok, B.
    Schluger, R.
    Sulaiman, I.
    Tsirigos, A.
    Moreira, A.
    Pass, H.
    Tsay, J. J.
    Segal, L. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [39] Discussion to: Comprehensive sampling of the lung microbiome in early-stage non-small cell lung cancer
    Reddy, Rishindra M.
    Yendamuri, Sai
    JTCVS OPEN, 2024, 17 : 269 - 270
  • [40] Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
    Liu, Yuanjun
    Zhu, Yaoyao
    Wu, Ran
    Hu, Min
    Zhang, Lingnan
    Lin, Qingren
    Weng, Denghu
    Sun, Xiaojiang
    Liu, Yu
    Xu, Yaping
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) : 2328 - 2336
12345